NPM3 (Nucleophosmin/Nucleoplasmin 3) is a member of the nucleophosmin/nucleoplasmin family, which plays critical roles in chromatin remodeling, histone chaperoning, and ribosome biogenesis. Unlike its well-studied homolog NPM1 (linked to cancer and ribosome assembly), NPM3 remains less characterized but shares structural features, including acidic domains for histone binding and nucleolar localization signals. It is implicated in early embryonic development, oocyte maturation, and epigenetic regulation, potentially through interactions with histones or transcription factors.
NPM3 antibodies are essential tools for studying its expression, localization, and molecular interactions. They enable detection via techniques like Western blot, immunofluorescence, and immunohistochemistry, aiding research on its role in cellular processes and diseases. Dysregulation of NPM3 has been tentatively associated with cancer (e.g., gliomas, leukemia) and developmental disorders, though mechanistic insights remain limited. Commercial antibodies typically target specific epitopes, such as the N-terminal region, and require validation for species cross-reactivity (human, mouse, rat). Recent studies also explore NPM3’s potential as a biomarker or therapeutic target, emphasizing the need for reliable antibodies to decipher its biological and pathological significance.